Han S, Hathcock K, Zheng B, Kepler T B, Hodes R, Kelsoe G
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore 21201, USA.
J Immunol. 1995 Jul 15;155(2):556-67.
Costimulatory interactions between T and B lymphocytes are crucial for T cell activation and B cell proliferation and differentiation. We have compared the roles of CD40L and B7-2 in the initiation and maturation of humoral immunity by administering anti-CD40 ligand (L) or anti-B7-2 Ab during the early (days -1 to 3) or late (days 6-10) phases of primary responses to thymus-dependent (Td) and -independent (Ti) Ags. Germinal center (GC) formation in response to a Td Ag was inhibited completely by the early administration of anti-CD40L or anti-B7-2 Abs. Later in the response, established GCs remained sensitive to anti-CD40L but were resistant to treatment with anti-B7-2. However, Ig hypermutation was reduced dramatically in GCs of anti-B7-2-treated mice and humoral memory was impaired. Early administration of anti-CD40L reduced serum Ab levels to approximately 10% of controls, whereas early treatment with anti-B7-2 reduced Ab production by only 50%. Later treatments with either Ab had no effect on Ab production. Response to a type II Ti Ag was more resistant than Td responses to interruption of costimulatory interactions. Our findings suggest that the costimulatory roles of CD40:CD40L and B7-2:CD28/CTLA-4 differ in the GC; administration of anti-CD40L abrogates an established GC reaction, whereas Ab to B7-2 suppresses Ig hypermutation and entry into the B cell memory compartment. Once B cells have entered the differentiation pathway to Ab production, neither CD40L nor B7-2 is necessary for their continued differentiation and persistence.
T淋巴细胞和B淋巴细胞之间的共刺激相互作用对于T细胞活化以及B细胞增殖和分化至关重要。我们通过在对胸腺依赖性(Td)和非胸腺依赖性(Ti)抗原的初次反应的早期(-1至3天)或晚期(6至10天)给予抗CD40配体(L)或抗B7-2抗体,比较了CD40L和B7-2在体液免疫启动和成熟中的作用。早期给予抗CD40L或抗B7-2抗体可完全抑制对Td抗原反应的生发中心(GC)形成。在反应后期,已形成的GC对抗CD40L仍敏感,但对抗B7-2治疗有抗性。然而,在抗B7-2处理的小鼠的GC中,Ig超突变显著减少,体液记忆受损。早期给予抗CD40L可使血清抗体水平降至对照组的约10%,而早期用抗B7-2治疗仅使抗体产生减少50%。后期用任何一种抗体治疗对抗体产生均无影响。对II型Ti抗原的反应比Td反应对共刺激相互作用中断更具抗性。我们的研究结果表明,CD40:CD40L和B7-2:CD28/CTLA-4在GC中的共刺激作用不同;给予抗CD40L可废除已建立的GC反应,而抗B7-2抗体则抑制Ig超突变并阻止进入B细胞记忆区室。一旦B细胞进入产生抗体的分化途径,CD40L和B7-2对于它们的持续分化和存活均非必需。